Suchergebnisse - "Kim, Sung-Hyun"

PubPharm (21)

1

Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role

enthalten in: Journal of proteome research | 2021

von Lee, M. | Na, K. | Shin, H. | +10

2

Biologic behavior of resected BRCA-mutated pancreatic cancer : Comparison with sporadic pancreatic cancer and other BRCA-related cancers

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2021

von Kim, S. | Hwang, H. | Lee, W. | +1

3

Targeting X chromosome-linked inhibitor of apoptosis protein in mucoepidermoid carcinoma of the head and neck : A novel therapeutic strategy using nitidine chloride

enthalten in: Journal of molecular medicine (Berlin, Germany) | 2020

von Kwon, H. | Yoon, K. | Jung, J. | +8

4

Prognostic potential of the preoperative plasma complement factor B in resected pancreatic cancer : A pilot study

enthalten in: Cancer biomarkers : section A of Disease markers | 2019

von Kim, S. | Lee, M. | Hwang, H. | +4

5

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Kim, H. | Kim, S. | Kim, H. | +10

6

Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib

enthalten in: Leukemia research | 2018

von Lee, S. | Choi, S. | Kim, S. | +8

7

Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy

enthalten in: The Korean journal of internal medicine | 2017

von Lee, S. | Kim, D. | Oh, S. | +10

8

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

enthalten in: Oncotarget | 2017

von Ahn, J. | Kim, H. | Kim, Y. | +17

9

Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer

enthalten in: Cancer research and treatment | 2016

von Kwon, K. | Yun, J. | Oh, S. | +7

10

DNA ligase4 as a prognostic marker in nasopharyngeal cancer patients treated with radiotherapy

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2014

von Kim, D. | Oh, S. | Kim, S. | +13